Matches in Wikidata for { <http://www.wikidata.org/entity/Q46287529> ?p ?o ?g. }
- Q46287529 description "2014 nî lūn-bûn" @default.
- Q46287529 description "2014年の論文" @default.
- Q46287529 description "2014年学术文章" @default.
- Q46287529 description "2014年学术文章" @default.
- Q46287529 description "2014年学术文章" @default.
- Q46287529 description "2014年学术文章" @default.
- Q46287529 description "2014年学术文章" @default.
- Q46287529 description "2014年学术文章" @default.
- Q46287529 description "2014年學術文章" @default.
- Q46287529 description "2014年學術文章" @default.
- Q46287529 description "2014年學術文章" @default.
- Q46287529 description "2014年學術文章" @default.
- Q46287529 description "2014年學術文章" @default.
- Q46287529 description "2014년 논문" @default.
- Q46287529 description "article científic" @default.
- Q46287529 description "article scientific" @default.
- Q46287529 description "article scientifique" @default.
- Q46287529 description "articol științific" @default.
- Q46287529 description "articolo scientifico" @default.
- Q46287529 description "artigo científico" @default.
- Q46287529 description "artigo científico" @default.
- Q46287529 description "artigo científico" @default.
- Q46287529 description "artikel ilmiah" @default.
- Q46287529 description "artikull shkencor" @default.
- Q46287529 description "artikulong pang-agham" @default.
- Q46287529 description "artykuł naukowy" @default.
- Q46287529 description "artículo científico publicado en 2014" @default.
- Q46287529 description "artículu científicu" @default.
- Q46287529 description "bilimsel makale" @default.
- Q46287529 description "bài báo khoa học" @default.
- Q46287529 description "naučni članak" @default.
- Q46287529 description "scienca artikolo" @default.
- Q46287529 description "scientific article published on 27 June 2014" @default.
- Q46287529 description "scientific article published on 27 June 2014" @default.
- Q46287529 description "scientific article published on 27 June 2014" @default.
- Q46287529 description "teaduslik artikkel" @default.
- Q46287529 description "tieteellinen artikkeli" @default.
- Q46287529 description "tudományos cikk" @default.
- Q46287529 description "vedecký článok" @default.
- Q46287529 description "vetenskaplig artikel" @default.
- Q46287529 description "videnskabelig artikel" @default.
- Q46287529 description "vitenskapelig artikkel" @default.
- Q46287529 description "vitskapeleg artikkel" @default.
- Q46287529 description "vědecký článek" @default.
- Q46287529 description "wetenschappelijk artikel" @default.
- Q46287529 description "wissenschaftlicher Artikel" @default.
- Q46287529 description "επιστημονικό άρθρο" @default.
- Q46287529 description "мақолаи илмӣ" @default.
- Q46287529 description "наукова стаття, опублікована в червні 2014" @default.
- Q46287529 description "научна статия" @default.
- Q46287529 description "научная статья" @default.
- Q46287529 description "научни чланак" @default.
- Q46287529 description "научни чланак" @default.
- Q46287529 description "מאמר מדעי" @default.
- Q46287529 description "مقالة علمية نشرت في 27 يونيو 2014" @default.
- Q46287529 description "২৭ জুন ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46287529 description "บทความทางวิทยาศาสตร์" @default.
- Q46287529 description "სამეცნიერო სტატია" @default.
- Q46287529 name "Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase" @default.
- Q46287529 name "Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase" @default.
- Q46287529 type Item @default.
- Q46287529 label "Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase" @default.
- Q46287529 label "Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase" @default.
- Q46287529 prefLabel "Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase" @default.
- Q46287529 prefLabel "Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase" @default.
- Q46287529 P1433 Q46287529-626E917A-FA50-4AAC-91E8-AB9E7027EFA1 @default.
- Q46287529 P1476 Q46287529-60D97DD8-6E6C-43DF-B37C-7FAF8C458F09 @default.
- Q46287529 P2093 Q46287529-01B1AA23-8C1C-4C82-B449-91D8CE939DDC @default.
- Q46287529 P2093 Q46287529-261CFA0A-B2FB-4C9F-940E-2951E80BE24C @default.
- Q46287529 P2093 Q46287529-7C913E6B-DAE5-4D70-8F1D-F386E1E500D8 @default.
- Q46287529 P2093 Q46287529-896A5C92-5EF9-4806-9236-10CAE19778A8 @default.
- Q46287529 P2093 Q46287529-A9383282-0095-4EB3-9CD1-59831264E21E @default.
- Q46287529 P304 Q46287529-D724C3AD-BB29-42BC-86B6-B2FB7434D159 @default.
- Q46287529 P31 Q46287529-DB97AEE2-C883-45BF-B950-EECCD2E7D474 @default.
- Q46287529 P356 Q46287529-2D16865C-DA1D-4729-9996-D7616C4A2E88 @default.
- Q46287529 P407 Q46287529-DD333402-1B5D-419C-A12F-E3AABBAE7DAB @default.
- Q46287529 P433 Q46287529-9C6349BF-4858-403B-8DF0-F950E5B53DB1 @default.
- Q46287529 P478 Q46287529-62C23CC6-F13F-439E-A52F-3276CB00B352 @default.
- Q46287529 P577 Q46287529-CF29C9DF-226B-43A3-A7AC-E36166CE11C0 @default.
- Q46287529 P698 Q46287529-1855565E-BE1C-4F02-8CD0-7DACAD9F2014 @default.
- Q46287529 P921 Q46287529-8BEFBFC8-D92D-4F35-8A7C-7F8D0E1AB1AF @default.
- Q46287529 P921 Q46287529-91806A03-D60C-4B8E-925C-B76A3142F9D4 @default.
- Q46287529 P356 ANNRHEUMDIS-2014-205325 @default.
- Q46287529 P698 24972708 @default.
- Q46287529 P1433 Q4767876 @default.
- Q46287529 P1476 "Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase" @default.
- Q46287529 P2093 "Johannes von Kempis" @default.
- Q46287529 P2093 "John R Tesser" @default.
- Q46287529 P2093 "Michael H Schiff" @default.
- Q46287529 P2093 "Ronald Goldblum" @default.
- Q46287529 P2093 "Ruediger B Mueller" @default.
- Q46287529 P304 "2174-2177" @default.
- Q46287529 P31 Q13442814 @default.
- Q46287529 P356 "10.1136/ANNRHEUMDIS-2014-205325" @default.
- Q46287529 P407 Q1860 @default.
- Q46287529 P433 "12" @default.
- Q46287529 P478 "73" @default.
- Q46287529 P577 "2014-06-27T00:00:00Z" @default.
- Q46287529 P698 "24972708" @default.
- Q46287529 P921 Q18032037 @default.